查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1655502

全球生物分解性支架市場

Biodegradable Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2030 年全球生物分解性支架市場規模將達 272 億美元

2024 年全球生物分解性支架市場規模估計為 45 億美元，預計到 2030 年將達到 272 億美元，2024-2030 年分析期間的複合年成長率為 35.0%。冠狀動脈支架是報告中分析的細分市場，預計其複合年成長率為 34.9%，到分析期結束時市場規模將達到 156 億美元。預計分析期內周邊動脈支架部分的複合年成長率為 35.2%。

美國市場規模估計為 11 億美元，中國市場預估年複合成長率為 42.8%

預計 2024 年美國生物分解性支架市場價值將達 11 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 85 億美元，2024-2030 年分析期間的複合年成長率為 42.8%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 26.8% 和 30.7%。在歐洲，德國的複合年成長率預計為 28.8%。

全球生物分解性支架市場 - 主要趨勢與促進因素摘要

為什麼生物分解性支架能夠徹底改變心血管照護？

生物分解性支架（也稱為生物可吸收支架）透過提供臨時的動脈支撐，正在改變心血管護理的模式。與無限期留在體內的傳統金屬支架不同，生物分解性支架會隨著時間推移而溶解，從而降低了支架內血管再阻塞和血栓症等長期併發症的風險。心血管疾病仍然是全世界發病率和死亡率的主要原因，開發一種不僅可以恢復血流而且可以在體內安全分解的支架代表著醫療技術的重大進步。對於需要長期副作用較少的微創治療的患者來說，這項創新至關重要。

生物分解性支架材料的最新創新有哪些？

生物分解性支架新材料的開發是醫療設備製造商關注的重點領域。早期的生物分解性支架由聚乳酸（PLA）等材料製成，但對更先進的聚合物和鎂基合金等金屬化合物的研究為提高性能開闢了新的可能性。這些新材料具有更高的機械強度、靈活性和可控的分解速率，能夠根據個別患者的需求客製化解決方案。此外，表面塗層的進步提高了生物相容性並減少了炎症，使得這些支架在管理長期心血管健康方面更有效。

生物分解性支架在心臟病學以外的用途有哪些？

生物分解性支架最初是為心臟病學開發的，但其用途正在擴展到其他醫學學科，包括胃腸病學、泌尿系統和整形外科。在胃腸外科手術中，生物分解性支架用於治療食道狹窄等病症，在泌尿系統中，可生物分解支架可為泌尿道提供暫時支撐。向新醫療領域的擴展凸顯了生物分解性支架技術的多功能性，使其成為廣泛專業領域微創手術的重要工具。這些支架在達到其目的後可以溶解，這對於需要臨時支架但不想永久植入的患者來說是革命性的。

生物分解性支架的廣泛應用面臨哪些挑戰？

儘管生物分解性支架具有諸多優點，但它也面臨一些可能限制其廣泛應用的挑戰。主要關注點之一是需要長期臨床資料來證明其與傳統支架相比的有效性。儘管該技術在臨床試驗中已顯示出良好的前景，但由於擔心機械完整性和過早劣化，一些醫療相關人員仍然猶豫不決。此外，與傳統支架相比，生物分解性支架的成本較高，這可能會成為成本敏感的醫療保健市場的障礙。透過持續的研究和開發解決這些問題對於充分發揮這項創新技術的潛力至關重要。生物分解性支架市場的成長受到多種因素的推動，例如心血管疾病盛行率的上升、生物材料技術的進步以及對微創手術的需求不斷成長。隨著患者偏好轉向最大限度減少異物滯留的治療方法，生物分解性支架提供了一個有希望的解決方案。證明這些設備的安全性和有效性的監管部門核准和臨床試驗也在推動市場成長。此外，生物分解性支架在非心臟應用中的使用日益增多，以及易患慢性疾病的老年人口不斷增加，進一步促進了對這些創新醫療設備的需求不斷成長。

部分

最終用途（醫院、心臟中心）；材料類型（聚合物基、金屬基）；支架類型（冠狀動脈支架、周邊動脈支架）

受訪公司範例（46家值得關注的公司）

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Sahajanand Medical Technologies Pvt., Ltd.
  • Terumo Europe NV

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP16208

Global Biodegradable Stents Market to Reach US$27.2 Billion by 2030

The global market for Biodegradable Stents estimated at US$4.5 Billion in the year 2024, is expected to reach US$27.2 Billion by 2030, growing at a CAGR of 35.0% over the analysis period 2024-2030. Coronary Artery Stents, one of the segments analyzed in the report, is expected to record a 34.9% CAGR and reach US$15.6 Billion by the end of the analysis period. Growth in the Peripheral Artery Stents segment is estimated at 35.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 42.8% CAGR

The Biodegradable Stents market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.5 Billion by the year 2030 trailing a CAGR of 42.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 26.8% and 30.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.8% CAGR.

Global Biodegradable Stents Market - Key Trends & Drivers Summarized

Why Are Biodegradable Stents Revolutionizing Cardiovascular Care?

Biodegradable stents, also known as bioresorbable stents, are transforming the landscape of cardiovascular treatment by offering a temporary scaffold for arterial support. Unlike traditional metal stents, which remain in the body indefinitely, biodegradable stents dissolve over time, reducing the risk of long-term complications such as in-stent restenosis and thrombosis. As cardiovascular diseases continue to be a leading cause of morbidity and mortality globally, the development of stents that not only restore blood flow but also degrade safely within the body is a major advancement in medical technology. This innovation is crucial for patients requiring minimally invasive treatments with reduced long-term side effects.

What Are the Latest Innovations in Biodegradable Stent Materials?

The development of new materials for biodegradable stents is a major area of focus for medical device manufacturers. Early biodegradable stents were made from materials like polylactic acid (PLA), but research into more advanced polymers and metallic compounds, such as magnesium-based alloys, has opened new possibilities for improved performance. These newer materials offer better mechanical strength, flexibility, and controlled degradation rates, allowing for more tailored solutions to individual patient needs. Moreover, advances in surface coatings are helping to enhance biocompatibility and reduce inflammation, making these stents more effective in the long-term management of cardiovascular health.

How Are Biodegradable Stents Expanding Beyond Cardiology?

While biodegradable stents were initially developed for cardiology applications, their use is expanding into other areas of medicine, such as gastroenterology, urology, and orthopedics. In gastrointestinal procedures, biodegradable stents are used to treat conditions like esophageal strictures, while in urology, they can provide temporary support in the urinary tract. This expansion into new medical fields underscores the versatility of biodegradable stent technology, making it an essential tool in minimally invasive procedures across a broad range of specialties. The ability of these stents to dissolve after serving their purpose is a game-changer for patients who require temporary scaffolding but do not want permanent implants.

What Are the Challenges in Widespread Adoption of Biodegradable Stents?

Despite their advantages, biodegradable stents face several challenges that could limit their widespread adoption. One of the primary concerns is the need for longer-term clinical data to prove their efficacy over traditional stents. While the technology has shown promise in clinical trials, there is still hesitation among some medical professionals due to concerns over mechanical integrity and premature degradation. Furthermore, the high cost of biodegradable stents compared to conventional stents can be a barrier in cost-sensitive healthcare markets. Addressing these concerns through continued research and development is essential to unlock the full potential of this innovative technology. The growth in the biodegradable stents market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in biomaterial technologies, and the growing demand for minimally invasive procedures. As patient preferences shift toward treatments that minimize foreign body retention, biodegradable stents offer a promising solution. Regulatory approvals and clinical trials demonstrating the safety and efficacy of these devices are also propelling market growth. Additionally, the expanding use of biodegradable stents in non-cardiac applications and the rising geriatric population, who are more prone to chronic diseases, are further contributing to the increased demand for these innovative medical devices.

SCOPE OF STUDY:

The report analyzes the Biodegradable Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Cardiac Centers); Material Type (Polymer Based, Metal Based); Stent Type (Coronary Artery Stents, Peripheral Artery Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Sahajanand Medical Technologies Pvt., Ltd.
  • Terumo Europe NV

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Biodegradable Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Driving Demand for Biodegradable Stents
    • Technological Advancements in Biodegradable Materials and Drug Elution
    • Growing Preference for Minimally Invasive Surgeries in Cardiology
    • Expanding Applications of Biodegradable Stents in Non-Cardiac Treatments
    • Increased Focus on Patient Safety and Reduction of Long-Term Complications
    • Regulatory Approvals Boosting Market Entry of Innovative Stents
    • Emerging Research on Bioabsorbable Polymers Enhancing Stent Performance
    • Impact of Aging Population and Rise in Lifestyle-Related Diseases
    • Rising Healthcare Expenditure in Developing Markets Fueling Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biodegradable Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Coronary Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Coronary Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Peripheral Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Peripheral Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Polymer Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Polymer Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Metal Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Metal Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • JAPAN
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • CHINA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • EUROPE
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • FRANCE
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • GERMANY
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Germany 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Italy 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • UNITED KINGDOM
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: UK 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • SPAIN
    • TABLE 72: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Spain 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 76: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Spain 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • RUSSIA
    • TABLE 78: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Russia 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 82: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Russia 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • AUSTRALIA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 98: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Australia 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 100: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Australia 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 102: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Australia 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • INDIA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 104: India Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: India 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 106: India Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: India 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 108: India Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: India 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 110: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: South Korea 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 112: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: South Korea 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 114: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: South Korea 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 116: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Asia-Pacific 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 118: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Asia-Pacific 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 120: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • LATIN AMERICA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 122: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 123: Latin America 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 124: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Latin America 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 126: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Latin America 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 130: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Argentina 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 132: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Argentina 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • BRAZIL
    • TABLE 136: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Brazil 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 138: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Brazil 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • MEXICO
    • TABLE 142: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Mexico 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 144: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Mexico 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 148: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of Latin America 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 150: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of Latin America 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • MIDDLE EAST
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 154: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 155: Middle East 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 156: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Middle East 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 160: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Middle East 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • IRAN
    • TABLE 162: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 163: Iran 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 164: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Iran 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 166: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Iran 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • ISRAEL
    • TABLE 168: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Israel 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 170: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Israel 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 172: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Israel 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 174: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Saudi Arabia 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 176: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Saudi Arabia 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 178: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Saudi Arabia 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 180: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 181: UAE 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 182: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: UAE 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 184: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 185: UAE 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 186: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Rest of Middle East 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 188: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Middle East 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 190: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 191: Rest of Middle East 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • AFRICA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 192: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 193: Africa 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 194: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Africa 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 196: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Africa 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030

IV. COMPETITION